Abiopharma

🔍 MORRIS SUSAN (Director)

Company: Albertsons Companies, Inc. (ACI)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 922 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 87,813.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 410 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 39,081.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 1,850 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 176,205.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 3,569 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 339,855.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: Performance Based Restricted stock units ("PBRSUs") credited to the reporting person's account as dividend equivalents on unvested PBRSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.17 per share of common stock.
• F2: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.17 per share of common stock.